Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Gil Roth
Advertisement
Gil Roth is president of the Pharma & Biopharma OutsourcingAssociation, [email protected].
Articles by Gil Roth
PTSM: Pharmaceutical Technology Sourcing and Management
Politics, drug prices, tax reform, regulatory uncertainty leave CDMOs/CMOs guessing about pharma’s future.
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Advertisement
Latest Updated Articles
- Viewpoint: Challenges and Opportunities for CDMOs
February 2nd 2017
- Viewpoint: No Clear Path for Pharma or Outsourcing
March 1st 2017
- CDMOs: New Administration, New Frontier
August 2nd 2017
Advertisement
Advertisement